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Some 25 years ago, the discovery that the cytoplasmic membrane of nerve terminals possesses
receptors that could modulate the release of neurotransmitters from the same nerve endings
was a revolutionary new concept in neurotransmission. Since then, prejunctional (or
presynaptic) receptors and their role in neurotransmission have remained the subject of
extensive research, mostly by using isolated organs or (brain) tissues, in viÍro, or by using
pithed or anaesthetized animals, in vivo. This thesis, however, describes studies using two
different models to investigate the modulatory role of prejunctional receptors in viy,o in
unanaesthetized, permanently instrumented unre sftained rat s.
About a decade ago, a model has been developed in our laboratory, which enables the
study of the function and the capacity of prejunctional receptors in the modulation of
noradrenaline oveÍflow in vivo in the vasculature of freely moving animals.In this model, the
preiunctional modulation of electrically evoked endogenous noradrenaline overflow is being
examined in the portal vein of these rats. To this purpose, rats are instrumented with two
cannulae in the portal vein, one for sampling blood and one (placed upstream of the first
cannula) for infusion of drugs, respectively. A bipolar stimulation electrode is placed around
the vein, between the two cannulae. To induce (local) noradrenaline overflow from the
sympathetic nervous plexus, the portal vein is stimulated by biphasic pulses. The rise of the
noradrenaline concentration in the portal plasma reflects the evoked noÍadrenaline overflow
from sympathetic nerve endings during electrical stimulation. To determine noradrenaline in
100 pl plasma samples, a sensitive HPLC method with electrochemical detection is used. To
determine postjunctional effects of drugs in the same experiment, an arterial cannula is
inserted in the abdominal aorta as well, for measuring blood pressure and heart rate and, in
some experiments also for the administration of drugs. Studies using this model are described
in chapters 2,5,6 and 7 of this thesis.
Exercise is a more physiological way of activating the sympathetic nervous system. In
the second model, swimming exercise is used to induce noradrenaline overflow. For these
experiments, the rats are provided with two cannulae in the left and right jugular vein for
infusion of drugs and sampling blood, respectively, and with an arterial cannula in the
abdominal aorta to measure blood pressure and heart rate. Exercise is performed by forcing
the animals to swim against a counteÍ current for 10 minutes. Experiments using swimming
exercise to induce noradrenaline overflow are described in chapters 3 and 4.
Chapters 2, 3 and 4 all face the role of NPY (which is a known co-transmitter of
noradrenaline in sympathetic nerve terminals) in the prejunctional modulation of
noradrenaline overflow; the postjunctional effects of NPY were monitored as well. In
addition, in chapters 2 and 3 the possible interactions between pre- as well as postjunctional




In chapter 2, the effect of G2-adrenoceptor act ivat ion or inactivation on the inhibitory
effects of NPY on electrically evoked noradrenaline overflow was studied. In addition, the
effects on the NPY-induced vasoconstr ict ion were investigated. Infusion of the selective
ch-adrenoceptor agonist oxymethazoline (0.01-1.0 pg/kg/min) resulted in a dose-dependent
inhibit ion of the evoked noradrenaline overf low. whereas administrat ion of the selective
cx,2-adrenoceptor antagonist yohimbine (0.5 mg/kg) enhanced electr ical ly evoked
noradrenaline overf low. NPY (2 pg/kg/min) inhibited electr ical ly evoked noradrenaline
overf low. When NPY was infused in combination with oxymethazoline (0. I  pg/kg/min), the
inhibitory effect of NPY turned out to be diminished. Administrat ion of yohimbine in
combination with NPY increased the effect of NPY, however. Postjunctionally, activation of
NPY receptors by NPY led to an increase in mean arterial pressure (MAP) and a decrease in
heart rate (HR). The highest dose of oxymethazoline also increased MAP and simultaneously
decreased HR. A lower dose of oxymethazoline (0. I  pg/kg/min), which by i tself  did not exert
an effect on MAP and HR, enhanced the vasopressor effects of NPY, and this combination
also decreased HR. In contrast, in the presence of yohimbine, the postjunctional effects of
NPY seemed to be suppressed. I t  was concluded that in the portal vein of the normal rat a
negative interaction exists between sr-adrenoceptors and NPY receptors at the prejunctional
level,  whereas postjunctional o2-adrenoceptors and NPY receptors may interact '"vi th each
other in a posit ive fashion.
In chapter 3, we investigated i f  such interactions between pre- and posdunctional
o:-adrenoceptors and NPY receptors were also operative during swimming exercise. In
addit ion, based on previous studies from our laboratory that had revealed (part ial ly)
dysfunctional prejunctional cl2-adrenoceptors in spontaneously hypertensive rats (SHR), the
effects of NPY on exercise-induced noradrenaline overf low as well  as on MAP and HR in
these hypertensive animals were determined. Exercise induced a strong increase in
catecholamine overf low, both in normo- and hypertensive animals. In SHR, noradrenaline and
adrenalíne levels were shown to be 2- and 3-fold higher, respectively, than attained in
(normotensive) Wistar rats (WR). In WR, NPY (2 pg/kg/min) inhibited exercise-induced
noradrenaline overf low. In addit ion. exercise-induced adrenaline overÍ low was inhibited.
When these rats were pre-treated with yohimbine (0.25 mg/kg) the inhibitory effects of NPY
on noradrenaline overf low were markedly enhanced, whereas the eÍ-fects on adrenaline
overf low were completely abol ished. In SHR, NPY was able to inhibit  exercise-induced
noradrenaline overf low to a much larger extent than in WR, plasma noradrenaline
concentrat ions reaching levels as low as those seen with NPY in yohimbine-treated WR; the
inhibitory effect of NPY on adrenaline overf low from the adrenal medulla of SHR appeared to
be diminished. Furthermore, in SHR, postjunctional vascular NPY receptors were shown to be
more responsive than in WR. The data did not provide evidence for a posit ive interaction
benveen NPY and cr-adrenergic receptors at the postjunctional level.  Therefore, i t  was
concluded that the enhanced vasopressor effect of NPY in SHR is solely related to hyperactive
posdunctional NPY receptors. In addit ion, the increased prejunctional effects of NPY in SHR
are rnost l ikely related to the diminished crz-adrenoceptor function in SHR, indicating a
negative interaction between prejunctional cxl-adrenoceptors and NPY receptors modulat ing
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medulla however, a positive interaction between those receptors modulating adrenaline
release appeared to be operative.
In chapter 4, the novel selective NPY Yr-receptor antagonist, BIBP3226, was used to
investigate the possible role of prejunctional and postjunctional NPY Yl-receptors in the
effects of NPY on noradrenaline overflow, blood pressure and heart rate in exercising SHR.
Exercise-induced noradrenaline as well as the adrenaline overflow were inhibited by NPY
(21tg/kg/min). BBP3226 (0.3, 0.9 and 3.0 mg/kC) dose-dependently reversed the effect on
noradrenaline overflow, whereas the inhibition of adrenaline overflow was abolished by the
lowest dose of BBP3226 already, reaching levels above control overflow. NPY increased
blood pressure prior to and during exercise, which was also dose-dependently reversed by
88P3226. The results confirm that the vasopressor effect of NPY was mediated by
postjunctional NPY Yr-receptors. Very interestingly, the inhibitory effects of NPY on
exercise-induced noradrenaline overflow appeared to be mediated, to a major extent, by
prejunctional NPY Y1-receptors. Furthermore, some role for endogenous NPY was indicated
in exerting an inhibitory influence on the release of adrenaline from the adrenal medulla
during exercise.
Chapter 5 analyzes the putative role of the co-transmitter ATP in modulating
noradrenaline overflow. We used the selective P2y-purinoceptor antagonist Reactive Blue 2
(RB2) (0.003 and 01-1.0 pmolikg), to determine the effect of endogenously released ATP on
electrically evoked noradrenaline release in the portal vein at two different frequencies (2Hz
and 15Hz). Atz}{z stimulation, RB2 dose-dependently inhibited noradrenaline overflow with
a high potency, whereas at l5Hz no significant effect was seen at all. Surprisingly, when
prejunctional a2-adrenoceptors were blocked ilth yohimbine (0.5 mC/kg), the yohimbine-
induced potentiation of noradrenaline overflow was dose-dependently inhibited to the same
extent at both frequencies. The results provided evidence for the involvement of a facilitatory
prejunctional P2y-purinoceptor in the portal vein, modulating the electrically evoked
noradrenaline overflow via endogenously released ATP. This facilitation is frequency-
dependent and was found to be subject to negative control by prejunctional d,2-adrenoceptors
activated by released noradrenaline.
The putative role for prejunctional histamine H3-receptors in the modulation of
electrically evoked noradrenaline overflow was investigated ïn chapter 6. The selective
histamine H3-receptor agonist R-cr-methylhistamine (0.01-1.0 pmol/kg) inhibited electrically
evoked noradrenaline overflow in the portal vein. The effect of R-cr-methylhistamine
( I .0 pmol/kg) was dose-dependently antagonized to control overflow by the selective
H3-receptor antagonist thioperamide (0.1,0.5 and 1.0 pmolikg). Thioperamide alone had no
effect on evoked noradrenaline overflow. Basal noradrenaline levels, blood pressure and heart
rate were not influenced by R-a-methylhistamine and thioperamide, alone or in combination.
These results clearly showed that prejunctional histamine H3-receptors exert an inhibitory
control on electrically evoked noradrenaline overflow in the portal vein; however, no evidence
for a role for postjunctional histamine Hl-receptors in regulating cardiovascular
hemodynamics was found. Furthermore, circulating histamine does noÍ seem to be in,,'olved jn




The f inal chapter (chapter 7) examines the possible relat ionship between the function
of prejunctional cr- and B-adrenoceptors modulat ing sympathetic neurotransmission and active
and passive behavioral coping styles in wild type rats (Raltus Norvegicus). In these rats, a
posit ive relat ionship between aggressiveness - performed in a resident- intruder test - and
catecholaminergic act ivi ty in response to social and non-social stressors had been reported.
Using the selective B:-adrenoceptor agonist fenoterol (0.0625,0. 125 and 0.25 mg/kg) and the
selective o2-adrenoceptor antagonist yohimbine (0.5 mg/kg), we establ ished the role of
prejunctional cx,2 - and p2-adrenoceptors in the modulat ion of basal and electr ical ly evoked
(2Hz,4msec, 10mA) noradrenaline overf low in the portal vein. In addit ion, the effects of
fenoterol and yohimbine on blood pressure and heart rate were established. In active rats,
fenoterol enhanced basal noradrenaline levels stronger than in passive rats. During electr ical
st imulat ion, the highest dose of fenoterol signif icantly faci l i tated evoked noradrenaline
overflow in active rats but not in passive rats. Also at the postjunctional level the effects of
fenoterol were more pronounced in active than in passive rats; fenoterol dose-dependently
decreased blood pressure to a stronger extent in act ive rats. Yohimbine increased basal as well
as electr ical ly evoked noradrenaline overf low to the same extent in both groups. When
fenoterol (0.0625 mg/kg) was administered in combination with yohimbine, basal
noradrenaline overf low increased further in both groups, which was, again, more pronounced
in active rats. Electr ical ly evoked noradrenaline overf low, however, was only increased
further in act ive rats. Thus, prejunctional as well  as posdunctional B2-adrenoceptors are less
functional in passive than in active wild type rats, and no dif ference in modulat ion of
noradrenaline overf low by prejunctional cx2-adrenoceptors appears to exist.
In conclusion, the studies described in this thesis have made clear that both NPY and ATP.
two major co-transmitters in the sympathetic nervous system, have an important modulatory
role in the sympathetic neuroeffector junction. Their role in the development and/or
maintenance of hypertension, in rest and during episodes of enhanced sympathetic act ivi ty,
remains to be establ ished further. however.
Hyperactive postjunctional NPY Yr-receptors, as found in the genetical ly hypertensive
animals, could obviously be involved. In addit ion, the negative interaction bet."veen
prejunctional NPY receptors and c2-adrenoceptors would diminish the inhibitory control by
NPY under such condit ions. On the other hand, prejunctional cx,:-adrenoceptor dysfunction (as
found in SHR) wil l  potentiate the NPY-mediated inhibit ion, implying that enhanced inhibit ion
through prejunctional NPY receptors compensates for the dysfunctional cx,2-adrenoceptor-
mediated control of noradrenaline release; part icularly during high sympathetic f i r ing rate (e.g.
stress) favouring NPY (and noradrenaline) release.
The other co-transmitter, ATP, is potentiat ing vascular noradrenaline overÍ low through
prejunctional P2y-receptors. In this thesis, the important observation has been made that
part icularly under low sympathetic f i r ing rate, endogenous ATP is exert ing a major faci l i tatory
control.  At higher frequencies - accompanied by increased noradrenaline overf lorv - this
faci l i tat ion is diminished or even abolished, due to enhanced negative interaction betrveen
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selective P2y-purinoceptor blockade during exercise, both in normotensive and in genetically
hypertensive animals. During exercise, noradrenaline levels in SHR were shown to be 2-fold
higher, which may be due (in part) to a facilitatory influence of ATP on noradrenaline
overflow.
As far as prejunctional histamine H3-receptors are concerned, which are clearly
capable of diminishing evoked noradrenaline overflow in the vasculature, it seems that
circulating plasma histamine concentrations during rest are insufficient to exert such
inhibitory control. Recent evidence, however, suggests that under certain pathophysiological
conditions including hypertension, endogenous H3-receptor activity becomes important. In
addition, it would be of interest to learn about the role of prejunctional H3-receptors in the
vascular sympathetic neuroeffector junction in allergic diseases such as asthma, during and
after allergen challenge.
The intriguing observation that active coping behavior of wild type rats in conflict
situations is accompanied by hyperactive prejunctional p2-adrenoceptors in peripheral
sympathetic nerve terminals, may imply that such animals underlie a higher risk to develop
high blood pressure when subjected to environmental stressors. In addition to dysfunctional
inhibitory cl,2-adrenoceptors in spontaneously hypertensive rats, enhanced pz-adrenoceptor
mediated-facilitation of noradrenaline overflow has been reported earlier in young SHR.
Consequently, it would be of interest to monitor the development of (high) blood pressure of
young active and passive rats, living in a stressful environment, in relation to changes of
prejunctional oz- and p2-adrenoceptor function controlling sympathetic neurotransmission in
these animals.
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